AGL earnings / call / takeaways
AGL earnings call: key takeaways
What AGL said on its earnings call of November 4, 2026: results against expectations, what changed since last quarter, guidance and the questions analysts pressed on.
By Lician·November 4, 2026·AI-generated from the call transcript and Lician data
Results vs expectations
| Metric | Consensus | Reported | Result |
|---|---|---|---|
| EPS | -$2.01 | – | – |
| Revenue | $1.46B | – | – |
What changed since last quarter
- The company raised full year 2026 guidance, citing stronger than expected performance in clinical pathways and favorable medical expense development. (14:58)
- ACO membership is expected to grow to 160,000 in 2027 from 110,000 today, driven by expanded partnerships. (16:36)
- The CFO mentioned a more modest benefit from contracting in 2027 compared to 2026, due to less of the book being repriced. (31:48)
Guidance
| Metric | This call | Previous call |
|---|---|---|
| Revenue | Full-year 2026 revenue of $5.88 billion. (14:58) | not captured |
| Other | Full-year 2026 medical services expense ratio of 90.4%. (14:58) | not captured |
| EBITDA | Full-year 2026 adjusted EBITDA of approximately $150 million. (14:58) | not captured |
| Other | ACO membership expected to grow to 160,000 by 2027. (16:36) | not captured |
What analysts pressed on
- Whether new markets and partners will be structured with full risk sharing arrangements or care coordination fees. (20:55)
- How the company will handle the reverse dynamic of participating in upside as bonus revenue recovers for payer partners. (23:39)
- Concerns about the remaining 5% of payers not on the enhanced data pipeline and the cost-benefit analysis for including them. (32:06)
In their words
We are continuing to roll out virtual pharmacy across our markets to drive greater adherence to GDMT and further improve performance.
(1:26)We believe our operational discipline is strengthening. Our clinical programs are becoming more systematic.
(7:24)We are taking a measured approach to that growth, prioritizing partnerships where we see strong alignment...
(5:49)We are proud of the progress across the business and we believe there is further opportunity ahead.
Jeffrey Schwaneke (16:36)
Read the full transcript with the AI summary, or listen on the company's official webcast.
Every past call in full and transcript search come with Lician Pro.
Written by AI from the automatic transcript of the company's public webcast and Lician's earnings data. Each sentence cites the passage it comes from, and a sentence with a figure that is not in its sources was removed. Not investment advice.